Advicenne Actions Nom.(Prom.) EO -,20

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

10.29%

Market Cap

20.89 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.66 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.68 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 01:31:04 PM
DAILY VOLUME (UNITS)6,716
DAILY HIGH / LOW1.771.4
PREV. DAY'S PRICE1.436 (07/20)
CHANGE DAY BEFORE
+0.24
16.99 %
52 WEEK HIGH / LOW2.21 (02/17)0.815 (05/26)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.67-0.53-0.66-0.47-0.44
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
-----
PRICE - SALES RATIO
9.484.864.19--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2H8SU
ISIN
FR0013296746
SYMBOL
3MM
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
ADVICENNE (PROM.) EO-,20
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
14.55 Mil.
MARKET CAPITALISATION
20.89 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-20.22 %
32.72 %
16.56 %
-12.12 %
10.29 %
-59.52 %
-79.16 %
-15.03 %
HIGH1.852.202.202.212.213.5110.152.21
LOW1.431.000.820.820.820.790.790.82

Dividende

pro Aktie
ADVICENNE (PROM.) EO-,20 does not deliver dividend information

Company profile

Advicenne SA is a pharmaceutical company, which engages in the development of innovative treatments in Nephrology. It develops treatment for both adults and kids. The company was founded in 2007 by Luc-André Granier and Caroline Roussel-Maupetit and is headquartered in Paris, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.